Company profile
Adolor company profile
Adolor Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of prescription pain and pain-management products. ENTEREG (alvimopan) is the United States Food and Drug Administration (FDA) approved product. ENTEREG is indicated to accelerate upper and lower gastrointestinal (GI) recovery following partial large or small bowel resection surgery with primary anastomosis. The Company is conducting two Phase 2 clinical trials of ADL5945 to treat opioid-induced constipation (OIC), a condition that often results from long-term use of opioid analgesics in the management of chronic pain conditions. In addition, it is continuing development efforts on ADL7445, a second peripherally-acting..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.adolor.com
- Phone number
- 17818601407
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00051-00100 employees
- Founded
- 1993-01-01
Headquarters
- Headquarters
- Exton, Pennsylvania, United States
- Postal code
- 19341
- Country code
- US
- Continent
- North America